From the Toronto Star, “The body of evidence to date overwhelmingly points to a causal connection between the use of Premplus and the development of invasive breast cancer in women,” the society’s Prithwish De wrote in a report to be filed in a Canadian class-action lawsuit against drug manufacturer Wyeth Canada, now owned by Pfizer. Read more information regarding expert studies on HRT and the class action lawsuit.
Posted on: Mon, 11 Aug 2014 21:40:29 +0000
Trending Topics
Recently Viewed Topics
© 2015